In January 2005, drug product patent protection was reintroduced in India to comply with the agreement on Trade Related Aspects of Intellectual Property Rights. How are the multinational pharmaceutical companies responding to the new policy environment? Is India likely to see monopolisation of the industry and high prices, which was the pattern before 1972 when India had product patent protection? Will the positive features of the post-1972 process patent era be diluted or negated?

In a landmark move, the Indian Patent Office announced on Monday that it has issued its first compulsory license to a domestic generic drug-maker. The decision effectively ends German pharmaceutical company Bayer AG's monopoly over an anti-cancer drug and authorises the production of a low-cost version for the Indian market.

Mumbai: In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture

This paper reviews theoretical and empirical literature that originated predominantly during and after TRIPS, focusing on the influence of changes in patent protection on developing countries. Previous studies identify two channels of gain for developing countries, from strong patent rights. Firstly, the promotion channel whereby, patent rights affect innovativeness of the South and concomitantly its economic growth. Theoretical studies do not give unambiguous hypotheses concerning the influence of patent protection on domestic innovation leaving it for empirical investigation.

In recent years, patenting has been considered one of the major drivers for enhancing national competitiveness and most of the advanced countries have been more actively enforcing patent protection. However, the indicators proposed in previous studies have not been able to deal adequately with the various dimensions of patenting, rather focusing on patent application counts. Therefore, in this research, a comprehensive patent performance indicator is proposed to provide a yardstick by which government policymakers can evaluate the whole process of converting patents into economic assets.

Sustainable agriculture and healthy nutrition are high on the social agenda. Work is now being done to face both challenges, often with measurable success. However, huge changes are still needed and some problems have even been exacerbated. Although agriculture and nutrition are closely linked, both issues are often dealt with in isolation.

The newly established Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, has been granted a patent by the Government of India for commercial production for the “Urea Detection in

Your data on changing stock prices for five pharmaceutical companies from 1997 to 2010 (Nature 480, 16–17; 2011) erroneously indicate a 39% drop in aggregated share value, when in fact it would have risen by 82% (see Correction, Nature 480, 425; 2011). The error was due mainly to the selection of unadjusted, rather than adjusted, stock-market closing prices. (Correspondence)

The present study tries to explore the factors that influence the growth, performance, and development of IPR attitude of small and medium-sized enterprises (SMEs) in the manufacturing sector of Punjab. The aim of the present research is to examine the technology management strategies of manufacturing SMEs, primarily on the basis of use-based classification.

Reed Beall and Randall Kuhn describe their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995.

Original Source

Pages